Registro:

Referencias:

• New, M.I., White, P.C., Pang Dupont S, B., Speiser, P.W., The Adrenal Hyperplasias in (1989) The Metabolic Basis of Inherited Disease, pp. 1881-1917. , (eds Scriver, C. R., Beaudet, A. L., Sly, S. & Valle, D.), McGraw-Hill
• Miller, W.L., Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency (1994) J. Clin. Endocrinol. Metab, 78, pp. 241-246
• Pang, S., Shook, M.K., Current status of neonatal screening for congenital adrenal hyperplasia (1997) Curr. Opin. Pediatr, 9, pp. 419-423
• Koppens, P.F., Family studies of the steroid 21-hydroxylase and complement C4 genes define 11 haplotypes in classical congenital adrenal hyperplasia in the Netherlands (1992) Eur. J. Pediatr, 151, pp. 885-892
• Blanchong, C.A., Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RPC4- CYP21-TNX (RCCX) modules in caucasians. the load of RCCX genetic diversity on major histocompatibility complexassociated disease (2000) J. Exp. Med, 191, pp. 2183-2196
• Donohoue, P.A., Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein (1986) J. Clin. Endocrinol. Metab, 62, pp. 995-1002
• Higashi, Y., Tanae, A., Inoue, H., Fujii-Kuriyama, Y., Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: Implications for steroid 21-hydroxylase deficiency (1988) Am. J. Hum. Genet, 42, pp. 17-25
• White, P.C., Speiser, P.W., Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2000) Endocr. Rev, 21, pp. 245-291
• Nelson, D.R., Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants (2004) Pharmacogenetics, 14, pp. 1-18
• Kominami, S., Ochi, H., Kobayashi, Y., Takemori, S., Studies on the steroid hydroxylation system in adrenal cortex microsomes. Purification and characterization of cytochrome P-450 specific for steroid C-21 hydroxylation (1980) J. Biol. Chem, 255, pp. 3386-3394
• Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., Fujii-Kuriyama, Y., Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene (1986) Proc. Natl. Acad. Sci. USA, 83, pp. 2841-2845
• White, P.C., New, M.I., Dupont, B., Structure of human steroid 21-hydroxylase genes (1986) Proc. Natl. Acad. Sci. USA, 83, pp. 5111-5115
• Robins, T., Carlsson, J., Sunnerhagen, M., Wedell, A., Persson, B., Molecular model of human CYP21 based on mammalian CYP2C5: Structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia (2006) Mol. Endocrinol, 20, pp. 2946-2964
• Pey, A.L., Stricher, F., Serrano, L., Martinez, A., Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases (2007) Am. J. Hum. Genet, 81, pp. 1006-1024
• Alibés, A., Using protein design algorithms to understand the molecular basis of disease caused by protein-DNA interactions: The Pax6 example (2010) Nucleic Acids Res, 38, pp. 7422-7431
• Minutolo, C., Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients (2011) PLoS One, 6
• Worth, C.L., Preissner, R., Blundell, T.L., SDM-a server for predicting effects of mutations on protein stability and malfunction (2011) Nucleic Acids Res, 39, pp. W215-W222
• Zhao, B., Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants (2012) J. Biol. Chem, 287, pp. 10613-10622
• Pallan, P.S., Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: Structure of the enzyme progesterone substrate complex and rate-limiting C-H bond cleavage (2015) J. Biol. Chem, 290, pp. 13128-13143
• Haider, S., Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia (2013) Proc. Natl. Acad. Sci. USA, 110, pp. 2605-2610
• Brønstad, I., Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia (2014) Endocr. Connect, 3, pp. 67-74
• Massimi, A., Functional and Structural Analysis of Four Novel Mutations of CYP21A2 Gene in Italian Patients with 21-Hydroxylase Deficiency (2014) Horm. Metab. Res, 46, pp. 515-520
• Taboas, M., Functional studies of p.R132C, p.R149C, p.M283V, p.E431K, and a novel c.652-2A> G mutations of the CYP21A2 gene (2014) PLoS One, 9
• Barbaro, M., In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia (2014) Clin. Endocrinol. (Oxf), 82, pp. 37-44
• Rodrigues, N.R., Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia (1987) EMBO J, 6, pp. 1653-1661
• Tardy, V., Gene symbol: CYP21A2. Disease: Steroid 21-hydroxylase deficiency (2006) Hum. Genet, 119, p. 363
• Tardy, V.T.V., Morel, Y., Gene symbol: CYP21A2 (2007) Hum. Genet, 121, p. 293
• Tardy, V.T.V., Gene symbol: CYP21A2 (2007) Hum. Genet, 121, pp. 292-293
• Wang, R., 21-Hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations (2016) Steroids, 108, pp. 47-55
• New, M.I., Genotype-phenotype correlation in 1, 507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency (2013) Proc. Natl. Acad. Sci. USA, 110, pp. 2611-2616
• Milacic, I., Molecular genetic study of congenital adrenal hyperplasia in Serbia: Novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations (2015) J. Endocrinol. Invest, 38, pp. 1199-1210
• Vrzalová, Z., Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency (2010) Int. J. Mol. Med, 26, pp. 595-603
• Speiser, P.W., New, M.I., White, P.C., Molecular Genetic Analysis of Nonclassic Steroid 21-Hydroxylase Deficiency Associated with HLA-B14, DR1 (1988) N. Engl. J. Med, 319, pp. 19-23
• Kirac, D., The Frequency and the Effects of 21-Hydroxylase Gene Defects in Congenital Adrenal Hyperplasia Patients (2014) Ann. Hum. Genet, 78, pp. 399-409
• Concolino, P., Mello, E., Zuppi, C., Capoluongo, E., Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: An update of new CYP21A2 mutations (2010) Clin. Chem. Lab. Med, 48, pp. 1057-1062
• Loke, K.Y., Lee, Y.S., Lee, W.W., Poh, L.K., Molecular analysis of CYP-21 mutations for congenital adrenal hyperplasia in Singapore (2001) Horm. Res, 55, pp. 179-184
• Ezquieta, B., Non-classical 21-hydroxylase deficiency in children: Association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations (2002) Acta Paediatr, 91, pp. 892-898
• Stikkelbroeck, N.M.M.L., CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in the Netherlands: Six novel mutations and a specific cluster of four mutations (2003) J. Clin. Endocrinol. Metab, 88, pp. 3852-3859
• Deneux, C., Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2001) J. Clin. Endocrinol. Metab, 86, pp. 207-213
• Bojunga, J., Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency (2005) Hum. Genet, 117, pp. 558-564
• Wasniewska, M., Novel mutation of CYP21A2 gene (N387K) affecting a non-conserved amino acid residue in exon 9 (2009) J Endocrinol Invest, 32, p. 633
• Baradaran-Heravi, A., Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran (2007) Clin. Endocrinol. (Oxf), 67, pp. 335-341
• Jiang, L., Identification and functional characterization of a novel mutation P459H and a rare mutation R483W in the CYP21A2 gene in two Chinese patients with simple virilizing form of congenital adrenal hyperplasia (2012) J. Endocrinol. Invest, 35, pp. 485-489
• Nadra, A.D., Serrano, L., Alibés, A., DNA-binding specificity prediction with FoldX (2011) Methods in Enzymology, 498, pp. 3-18
• Wu, D.A., Chung, B., Mutations of P45Oc21 (Steroid 21-Hydroxylase) at Cys428, Val281, and Serf " Result in Complete, Partial, or No Loss of Enzymatic Activity, Respectively (1991) J. Clin. Invest, 88, pp. 519-523
• Ozturk, I.C., Wei, W.-L., Palaniappan, L., Rubenfire, M., Killeenas, A.A., Analysis of CYP21 Coding Polymorphisms in Three Ethnic Populations: Further Evidence of Nonamplifying CYP21 Alleles among Whites (2000) Mol. Diagnosis, 5, pp. 47-52
• Asanuma, A., Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency (1999) J. Hum. Genet, 44, pp. 312-317
• Dolzan, V., Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia (2005) Eur. J. Endocrinol, 153, pp. 99-106
• Nikoshkov, A., Lajic, S., Holst, M., Wedell, A., Luthman, H., Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency (1997) J. Clin. Endocrinol. Metab, 82, pp. 194-199
• Menassa, R., P.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency (2008) J. Clin. Endocrinol. Metab, 93, pp. 1901-1908
• Tardy, V., Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier (2010) J. Clin. Endocrinol. Metab, 95, pp. 1288-1300
• Sherry, S.T., DbSNP: The NCBI database of genetic variation (2001) Nucleic Acids Res, 29, pp. 308-311
• Sudmant, P.H., An integrated map of structural variation in 2, 504 human genomes (2015) Nature, 526, pp. 75-81
• Sali, A., Blundell, T.L., Comparative protein modelling by satisfaction of spatial restraints (1993) J. Mol. Biol, 234, pp. 779-815
• Tamura, K., Dudley, J., Nei, M., Kumar, S., MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0 (2007) Mol. Biol. Evol, 24, pp. 1596-1599
• Shen, M.-Y., Sali, A., Statistical potential for assessment and prediction of protein structures (2006) Protein Sci, 15, pp. 2507-2524
• Benkert, P., Biasini, M., Schwede, T., Toward the estimation of the absolute quality of individual protein structure models (2011) Bioinformatics, 27, pp. 343-350
• Ramachandran, G.N., Ramakrishnan, C., Sasisekharan, V., Stereochemistry of polypeptide chain configurations (1963) J. Mol. Biol, 7, pp. 95-99
• Schymkowitz, J., The FoldX web server: An online force field (2005) Nucleic Acids Res, 33, pp. W382-W388
• Soardi, F.C., Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients (2008) J Clin Endocrinol Metab, 93, pp. 2416-2420
• Speiser, P.W., Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline (2010) J Clin Endocrinol Metab, 95, pp. 4133-4160

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------